相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes
Guenter Mueller et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: Compared effects of once-versus twice-daily dosing
Michihiro Matsuki et al.
ENDOCRINE JOURNAL (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
Theodore Mazzone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial
Guillermo Umpierrez et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Glimepiride pharmacokinetics in obese versus non-obese diabetic patients
UA Shukla et al.
ANNALS OF PHARMACOTHERAPY (2004)
Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy
D McCluskey et al.
CLINICAL THERAPEUTICS (2004)
The role of glimepiride in the effective management of Type 2 diabetes
SN Davis
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Benefits of combination therapy of insulin and oral hypoglycemic agents
AJ Garber
ARCHIVES OF INTERNAL MEDICINE (2003)
Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
A Fritsche et al.
ANNALS OF INTERNAL MEDICINE (2003)
Glimepiride in type 2 diabetes mellitus: A review of the worldwide therapeutic experience
M Massi-Benedetti
CLINICAL THERAPEUTICS (2003)
Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus
MU Kabadi et al.
ANNALS OF PHARMACOTHERAPY (2003)
Change in patients' body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrolective cohort study
S Martin et al.
DIABETOLOGIA (2003)
Effect of glimepiride on insulin-stimulated glycogen synthesis in cultured human skeletal muscle cells
A Haupt et al.
DIABETES CARE (2002)
Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes
D Overkamp et al.
DIABETES CARE (2002)
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes
M Korytkowski et al.
DIABETES CARE (2002)
Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
A Holstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients
G Charpentier et al.
DIABETIC MEDICINE (2001)
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide
MM Mocanu et al.
CIRCULATION (2001)
Glimepiride block of cloned ß-cell, cardiac and smooth muscle KATP channels
DK Song et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Efficacy and tolerability of glimepiride in daily practice - A non-interventional observational cohort study
GH Scholz et al.
CLINICAL DRUG INVESTIGATION (2001)
分享论文
